Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2025-03-30
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Necrotizing Enterocolitis of Premature Newborns Under Less Than 1500 g Using Probiotics
NCT02245815
Digestive and Nutritional Effects of Probiotics Supplementation in Premature Newborns
NCT00290576
Effects of Probiotic and Prebiotic Combinations on Premature Infants
NCT00282113
Probiotics On Resistant Bacteria Colonization In Preterm Receiving Antibiotics
NCT02178267
Study the Safety and Efficacy of Probiotics Use in Premature Infants
NCT01891604
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Approval was obtained from the hospital's clinical research ethics committee before starting the study. The decision to start probiotics was made when these premature babies were fully enteral fed. The study design was created as a cohort and case-control study (No randomisation). When clinicians decided to start probiotic support for premature babies with good general health and no additional problems, probiotics were added to the baby's order.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Preterm infants receiving probiotics
Probiotic mix preparation
Bifidobacterium containing supplement with vitamin D will start after preterm infants reaches full enteral feeding
Bifidobacteria
Rather than early period we will start probiotics after infant receive full enteral feedings
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic mix preparation
Bifidobacterium containing supplement with vitamin D will start after preterm infants reaches full enteral feeding
Bifidobacteria
Rather than early period we will start probiotics after infant receive full enteral feedings
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
7 Days
3 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fuat Emre Canpolat
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FUAT EMRE CANPOLAT, MD
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ABSH-Neo-Pro1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.